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Background: Left ventricular thrombus (LVT) formation occasionally complicates patient recovery post myocardial
infarction, conveying a significant risk of systemic embolism. Accordingly, thrombus detection and subsequent
anticoagulation is imperative in order to minimize patient morbidity and mortality. Transthoracic echocardiography
(TTE) is the imaging modality most widely used to screen for thrombus formation despite its suboptimal sensitivity
and specificity.
Case presentation: This report describes the discordant imaging findings of a LVT in a 56 year old Caucasian male
with an anterior ST elevation myocardial infarction. Left ventriculography revealed a filling defect, suggestive of a
potential left ventricular (LV) thrombus, which could not be confirmed by TTE. Cardiac magnetic resonance imaging
(MRI) demonstrated evidence of a full thickness scar involving the mid to distal anterior wall and apical regions,
with confirmation of a small LV apical thrombus.
Conclusions: This case illustrates the limitations of TTE when used as a tool to screen for thrombus formation. It
highlights the importance of multimodality cardiac imaging for the detection of post myocardial infarction (MI)
complications, in the context of a high clinical suspicion.
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Left ventricular thrombus (LVT) formation constitutes a
significant concern for patients post myocardial infarc-
tion (MI). Approximately 4% of ST elevation myocardial
infarction (STEMI) patients treated aggressively with
primary percutaneous intervention (PCI) therapy dem-
onstrate evidence of a LVT by contrast echocardiog-
raphy [1]. The majority (75%) of LV thrombi are apical
in location, reflecting common patterns of injury and
blood stasis [2,3]. MI plays a role in the pathogenesis of
a LVT by contributing to Virchow’s Triad of predispos-
ing factors including: i) endothelial injury from ischemic
insult; ii) hypercoagulability secondary to an increase in
procoagulant factors; and iii) stasis from akinetic nec-
rotic myocardium, especially at the apex [4]. Certain car-
diac characteristics, representative of transmural infarcts* Correspondence: djassal@sbgh.mb.ca
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emerged as predictors of LVT formation. These include
a reduced ejection fraction (EF), anteriorly located in-
farct, regional wall motion abnormalities, and multiple
aneurysms [1,3,5].
The significance of LV thrombi stems not only from its
epidemiology but also its associated morbidity and mortal-
ity; a LVT often accompanies larger infarcts and conveys
the risk of systemic embolism [1,3]. Thus, treatment of a
LVT is aggressive, involving anticoagulation with warfarin
for at least three months [6,7]. Novel anticoagulants, such
as dabigatran, have yet to be approved for LVT anticoagu-
lation, despite extensive use for stroke prevention in atrial
fibrillation [7]. The convenience of transthoracic echocar-
diography (TTE) has led to its widespread use in the de-
tection of LV thrombi, despite certain limitations. Its
efficacy however, is improved with the concomitant use of
contrast or other imaging modalities.
Case presentation
A 56 year old Caucasian male with an anterior STEMI
underwent PCI of the left anterior descending arteryhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Left ventriculography in a right anterior oblique view
demonstrating a filling defect within the left ventricular apex
suggestive of an apical thrombus.
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a filling defect within the inferoapical region suggestive
of a potential LV thrombus (Figure 1). Subsequent TTE
with contrast confirmed mild LV systolic dysfunction
with an EF of 40-45% with akinesis of the apex. How-
ever, a LV apical thrombus could not be confirmed on
contrast TTE (Figure 2). Due to this discrepancy in find-
ings, cardiac MRI (CMR) was performed which demon-
strated evidence of full thickness scar involving the mid
to distal anterior wall and apical regions, with confirm-
ation of a small LV apical thrombus measuring 10 x 5 mm
in dimension (Figure 3). Multimodality cardiac imaging
may be required in the clinical detection of post MI com-
plications, including an apical thrombus.
Discussion
This case illustrates the importance of multimodality im-
aging in the clinical detection of a LVT when a high de-
gree of suspicion exists. TTE alone was unable to
adequately visualize the source of the filling defect demon-
strated by left ventriculography. The use of CMR wasFigure 2 Parasternal short axis view (A), apical 2 chamber view (B), an
with contrast demonstrating no evidence of an apical thrombus.necessary in this report to confirm the presence of a
thrombus, serving to highlight its superior sensitivity and
specificity, as well as the limitations of other imaging mo-
dalities in thrombus detection.
Left ventriculography is a useful imaging modality to
screen for LVT in patients undergoing cardiac catheteri-
zation post-MI, as was seen in this case. Thrombi appear
as discrete filling defects in areas of akinesia or dyskin-
esia [8]. Ventriculography, however is limited by a low
sensitivity (31%) and specificity (75%), which may dir-
ectly result from a number of factors: failure of contrast
to mix in dyskinetic areas, obscuration of filling defects
by overlying material, and/or difficulty differentiating
thrombi from normal cardiac architecture, such as trabe-
culations [8]. As a result, abnormal vetriculographic
findings are verified by TTE.
TTE remains the imaging modality most widely used
to screen for LV thrombi, as it is cost effective, access-
ible, and non-invasive. A LVT appears as an echo-dense
mass distinct from the LV wall, but adjacent to an area
of abnormal wall motion [5]. Despite the widespread use
of TTE, diagnostic performance is suboptimal with a
sensitivity of only 33% and specificity of 91% [9]. TTE
can be technically challenging as a result of an indistin-
guishable myocardial-thrombus interface, foreshortening
of the LV apex or poor visualization of small protuberant
thrombi or mural thrombi of any size [3]. In fact, TTE
can only detect around 10% of thrombi less than 1 cm
in size, which may explain why the LVT was not de-
tected by TTE in this clinical case [3]. Contrast echocar-
diography has been shown to significantly improve
detection of a LVT (sensitivity and specificity are 61%
and 99% respectively), enhancing endocardial border
definition and overall image quality [2]. Thus, contrast
echocardiography is recommended for consideration
when standard imaging proves inconclusive, which may
be in as many as half of imaging studies [10].
In contrast to TTE, which identifies a LVT based on
anatomic appearance, delayed enhancement CMR (DE-
CMR) relies on tissue characterization. The avascular
LVT is viewed as an absence of contrast uptake adjacent
to hyperenhanced scarred myocardium [3]. DE-CMR isd apical 4 chamber view (C) on transthoracic echocardiography
Figure 3 Delayed enhancement cardiac magnetic resonance imaging sequence in the short axis view (A), apical 2 chamber view (B),
and apical 4 chamber view (C) confirming full thickness scar involving the mid to distal anterior wall and apical regions, with
delineation of a small left ventricular apical thrombus measuring 10 x 5 mm in dimension.
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detection, with a sensitivity of 88% ± 9% and specificity
of 99% ± 2% [3]. Furthermore, DE-CMR is better suited
for detecting small thrombi; sensitivity only begins to
decrease when imaging masses of less than 1 cm in size
[3]. Therefore, when other imaging modalities demon-
strate discordant findings, the use of CMR is warranted
in order to rule out potentially fatal complications for
patients post MI.
Conclusion
The current case illustrates the difficulty associated with
LVT detection, as imaging modalities used to screen pa-
tients post MI are imperfect. When clinical suspicion is
high and imaging results discordant, a third modality
should be sought.
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